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Quantitative reduction of portal blood flow following a portacaval shunt (PCS) adversely affects 
hepatocyte function, but does not alter HRES activity [L. P. Edgcomb, J. A. Knol, and F. E. Eckhauser. 
J. Surg. Rex 33: 233, 19821. To determine whether similar changes occur after qualitative alteration 
of portal blood flow, portacaval transpositions (PCT) were constructed in six conditioned mongrel dogs. 
Estimated hepatic blood flow (EHBF) was determined scintigraphically by the rate of hepatic uptake 
of a SO@pCi dose of 99mTc-sulfur colloid (Tsc). Hepatic reticuloendothelial cell (RES) phagocytic (PI) 
and degradative (DI) indices were calculated from the half-time blood disappearance of “‘I-labeled RES 
test lipid emulsion, and the half-time urine appearance of free ‘3’1, respectively. Opsonic activity (01) 
was determined by gelatin latex particle agglutination and normalized to control values. Hepatocellular 
function was assessed by serial determinations of albumin (Alb), and pyruvic and glutamic oxaloacetic 
transaminases (SGPT and SCOT). All studies were performed prior to and at 3,6, and 9 weeks following 
PCS or PCT. Conclusions: In the dog, neither PCS nor PCT adversely affected HRES activity. Hepa- 
tocellular function and 01 remained unchanged following PCT but deteriorated significantly after PCS. 
Observed changes in hepatocyte function and 01 following PCS suggest that hepatocellular integrity 
and serum opsonic activity may be interrelated. 
INTRODUCTION 
Child in the early 1950s stressed that liver 
regeneration following portacaval transposi- 
tion and partial hepatectomy was related di- 
rectly to maintaining the “quantity” of portal 
blood flow [8]. Bollman also described pro- 
gressive hepatic atrophy and loss of functional 
reserve following portal diversion and attrib- 
uted this to deprivation of portal blood [4]. 
In contrast, Fischer and others have recently 
reemphasized the importance of hormonal 
and other factors in portal blood in sustaining 
liver regeneration and functional integrity [8, 
12, 13, 291. 
Phagocytic and metabolic (degradative) 
functions of the hepatic reticuloendothelial 
system (HRES) have recently been shown to 
be unaffected by portal diversion despite 
marked hepatocellular dysfunction [ 111. It is 
common knowledge that blockage of the 
HRES may result from depletion of circulating 
serum opsonic proteins [21, 241 and marked 
decreases in both HRES activity and serum 
levels of opsonic protein have been demon- 
strated after surgery, trauma, bums, and he- 
patic failure [ 17, 22, 271. However, it is not 
known how portal diversion affects serum op- 
sonic activity or the functional state of the 
HRES. 
The purpose of this study was to determine 
the acute affects of complete portal blood flow 
diversion (PCS) on hepatocellular and HRES 
structure and function. Portacaval transpo- 
sitions (PCT) were created to determine 
whether qualitative alteration of portal blood 
flow had similar effects on hepatocellular and 
HRES parameters. Finally, an attempt was 
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made to relate observed changes in hepato- 
cellular function to long-term alterations in 
serum opsonic activity. 
MATERIALS AND METHODS 
Eighteen mongrel dogs lo-30 kg body wt 
were maintained on standard kennel chow and 
water ad libitum. Each animal underwent se- 
rial determinations of liver function tests and 
(HRES), phagocytic (PI), and degradative (DI) 
indices as well as determinations of serum op- 
sonic activity (01), and estimated hepatic 
blood flow (EHBF). 
Liver function was assessed by determining 
serum levels of glutamic oxaloacetic trans- 
aminase (SGOT), glutamic pyruvic trans- 
aminase (SGPT), total protein (TP), and al- 
bumin (Alb). Changes in protein subgroups 
were determined by protein electrophoresis. 
HRES phagocytic and degradative activity 
was determined with a gelatinized RES test 
lipid emulsion technique developed by Di- 
Luzio and Riggi [ IO] and described previously 
[ 111. This test lipid emulsion has been shown 
to be taken up selectively by the reticuloen- 
dothelial system and 90% of the emulsion is 
removed by the Kupffer cell population in the 
liver [9]. 
Each animal received an intravenous dose 
of 150 mg/kg of anhydrous base equivalent 
emulsion containing 30 to 50 &i of 13’I. Ten 
drops of Lugol’s solution was administered to 
all test animals to prevent thyroid uptake of 
the radiotracer. The test lipid emulsion was 
administered intravenously over 60 set to 
awake, restrained animals. Four milliliters of 
central venous blood was withdrawn every 
minute for 10 min then every 15 min for a 
total of 2 hr. One-milliliter aliquots of protein 
and lipid devoid supematant obtained by tri- 
chloroacetic acid precipitation were saved for 
assay of free serum 13’1 Urinary output was . 
collected at 15min intervals and recorded for 
the 2-hr test period. One-milliliter aliquots 
from each 5-min collection period were saved 
for measurements of urine 13’I. Deiodination 
of phagocytized ’ 3 ‘I-labeled lipid particles re- 
sults from HRES metabolic activity. Serum 
levels of free 13’1 activity were measured. Fif- 
teen-minute urine samples were also assayed 
to determine the rate of appearance of 
free “‘I. 
Serum opsonic activity was determined ac- 
cording to the method of Check et al. [7] mea- 
suring the ability of serum samples to cause 
agglutination of gelatin-coated carboxy-latex 
particles in the presence of heparin. Activity 
indices varied widely among study animals. 
Therefore, values were normalized to control 
values and plotted as mean percentage activity 
versus time. 
Estimated hepatic blood flow was deter- 
mined scintigraphically by measuring the rate 
of hepatic uptake of a “subcritical” dose of 
500 &i of 99*Tc-sulfur colloid (Tsc) [ 15, 191. 
After rapid intravenous injection of Tsc, ra- 
dioactivity was counted using a 2.5-cm di- 
ameter NaI gamma probe positioned exter- 
nally over the animal’s liver, and read on a 
Tracer Northern multichannel analyzer at 140 
keV + 30% windows. 
Six animals underwent end-to-side porta- 
caval shunt (PCS), six underwent portacaval 
transposition (PCT), and six underwent peri- 
portal and caval dissection only (controls). All 
animals were studied preoperatively and at 3, 
6, and 9 weeks postoperatively. At the com- 
pletion of the study, each animal was given 1 
mCi of Tsc intravenously over 5 min and sac- 
rificed. A subsequent open liver biopsy was 
immediately fixed in 10% buffered formalin 
and 2% glutaraldehyde for light and electron 
microscopy, respectively. Exsanguinated liver, 
spleen, lung, and proximal femur bone mar- 
row were weighed. Each tissue was assayed 
for radioactivity/gram tissue weight in a well 
scintillation counter at 140 keV f 10% win- 
dow for 9gmT~. Tissue distribution was ex- 
pressed as the percentage injected dose phago- 
cytized per gram tissue for each organ (% 
ID/g) and per total organ (% ID/TO). Bone 
marrow was assumed to represent 2% body 
wt. All data was represented as X t SD and 
analyzed using Student’s t and unpaired t tests. 
Preoperative data were compared to that ob- 
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tamed at 3,6, and 9 weeks following operation lowing either PCS or PCT compared to con- 
and to controls when appropriate. trols by 9 weeks postoperatively. 
RESULTS 
Following operation, serum levels of SGOT 
increased significantly (P < 0.05) in the PCS 
group compared to either the control or PCT 
group. There was no significant increase in 
SGOT following PCT. Similarly, serum levels 
of SGPT were significantly elevated following 
PCS compared to controls at 3 and 6 weeks, 
but returned toward normal by 9 weeks post- 
operatively. In the PCT group, the SGPT ele- 
vations observed at 3 weeks were not signif- 
icant compared to controls. In addition, SGPT 
levels in PCS animals were significantly ele- 
vated (P < 0.05) to those observed in PCT 
animals at both 3 and 6 weeks postoperatively. 
Intravenous dosages of BES test lipid emul- 
sion were adjusted during the study according 
to animal weight; no significant changes in 
total dosage or animal weight were observed 
after PCS or PCT compared to controls. There 
was no significant change observed in the half- 
time blood clearance of lipid at 3, 6, or 9 
weeks following PCS or PCT. Similarly, there 
was no change observed in the half-time urine 
appearance of free 13’1 after PCS or PCT com- 
pared to preoperative or control values. 
Serum levels of total protein and albumin 
declined following PCS. Serum total protein 
was significantly decreased in the PCS versus 
PCT group by 6 and 9 weeks, and was sig- 
nificantly depressed compared to controls by 
9 weeks postoperatively. Albumin levels in 
the PCS versus control groups were signifi- 
cantly depressed by 6 and 9 weeks postop 
eratively, and significantly depressed as com- 
pared to the PCT group by 9 weeks postop- 
eratively. There was no observable change in 
either serum total protein or albumin in the 
PCT group compared to controls after the 9- 
week study period (Table 1). Serum levels of 
a*-proteins did not change significantly fol- 
Opsonic activity represented as a percentage 
of preoperative activity declined after PCS. At 
6 and 9 weeks following PCS, these values 
were significantly less than levels measured in 
control and PCT groups (P < 0.01 and P 
< 0.001, respectively). A 23% decrease in op- 
sonic activity was observed in the PCT group 
at 9 weeks but this was not significant com- 
pared to controls (Fig. 1). 
Estimated hepatic blood flow (EHBF) de- 
clined significantly by 3 weeks following PCS 
from 49.1 f 3.5 to 26.9 f 2.7 ml/min/kg body 
wt (P < 0.005). Following PCT, EHBF rose 
significantly from control preoperative values 
to 62.5 f 10.5 ml/min/kg body wt (P < 0.005). 
Attempts to autoregulate or return EHBF to 
normal levels were not observed in either PCT 
or PCS groups. Once blood flow had resta- 
bilized by 3 weeks postoperatively, no signif- 
icant variation occurred in subsequent mea- 
















Control 6.08 t 0.33 2.40 + 0.35 6.25 + 0.92 2.58 + 0.18 
PCS 5.70 + 0.70 2.32 + 0.23 5.35 + 0.68t 2.10 + 0.24* 5.45 + 0.42*q 2.07 f O.l9**t 
PCT 6.43 zk 0.31 2.52 _+ 0.30 6.45 + 0.24 2.48 + 0.37 6.65 f 0.37 2.55 + 0.15 
u Serum levels of total protein (TP) and albumin (Alb) are in mgjdl. 
* P < 0.05, PCS versus control. 
tP < 0.05, PCS versus PCT. 
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FIG. 1. Normalized serum opsonic activity declined 
gradually following PCT but by 9 weeks postoperatively 
was not significantly different than in controls. Corre- 
sponding serum opsonic activity following PCS was sig- 
nificantly reduced below preoperative and PCT values at 
6 and 9 weeks, respectively. 
There was no significant change in the organ 
weight-to-body weight ratio for liver, spleen, 
or lung following PCT. In contrast, the liver 
weight-to-body weight ratio following PCS 
decreased significantly compared to PCT (P 
< 0.05) and control (P < 0.0 1) groups. Similar 
changes were not observed for spleen or lung. 
The organ distribution of phagocytized ra- 
diolabeled particles changed dramatically fol- 
lowing PCT and PCS. Total liver radioactivity 
was significantly decreased after both PCS (P 
< 0.0 1) and PCT (P < 0.05). The 45% decrease 
in total liver radioactivity observed following 
PCS was significantly greater than that ob- 
served following PCT (33%, P -c 0.05). Com- 
pared to controls or PCT, significantly greater 
amounts of phagocytized activity were found 
in spleen, lung, and bone marrow following 
PCS. Corresponding determinations of organ 
activity for spleen, lung, and bone marrow 
following PCT versus controls were not sig- 
nificantly different, but were significantly 
lower than similar values after PCS (P < 0.05) 
(Fig. 3). The tissue distribution of phagocytized 
activity following intravenous injection of 1 
mCi of Tsc in the PCS group demonstrated 
a significant concentration of activity per gram 
tissue in both liver and spleen compared to 
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FIG. 2. Illustrates the significant fall in (estimated hepatic 
blood flow) EHBF following PCS and the significant rise 
in EHBF following PCT. Once new levels had been 
achieved, subsequent changes did not occur. 
PCT no significant changes in the tissue con- 
centrations of phagocytized activity were de- 
tected (Table 2). 
Light and electron microscopy of liver from 
control animals was normal. In contrast, PCS 
and PCT caused demonstrable light and elec- 
tron microscopic changes in liver morphology. 
Following both PCS and PCT, hepatocytes 
developed an eosinophilic, finely granular cy- 
toplasm and appeared reduced in size. There 
appeared to be a greater loss of hepatocyte 
glycogen in the PCS group than in the PCT 
group. Dilatation of the hepatic sinusoids was 













* p c .Oi PCS compared to shams 
+ P < .OS PCS compared to PCT 
+ p < .05 PCT compared to shams 
Liver Spleen Lung Bone Marrow 
FIG. 3. Percentage tissue distribution of Tsc activity 
following PCS shows a significant shift away from liver 
to spleen, lung, and bone marrow. A similar but lesser 
reduction in liver activity was seen after PCT compared 
to controls. Spleen activity following PCT was similar to 
controls and both were significantly less than corresponding 
values after PCS. 
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TABLE 2 
Emcr OF PORTACAVAL SHUNT AND PORTACAVAL TRANSPOSITION ON TISSUE DISTRIBUTION 
OF INTRAVENOUSLY INJECTED 99mT~ 
Liver Lung Spleen 
Experimental 
groups %ID/g %ID/TO %ID/g %ID/TO %ID/g %ID/TO 
Control 0. I4 t 0.03 82.7 + 6.3 0.07 + 0.07 2.3 f 1.3 0.05 f 0.02 6.7 + 2.7 
PCS 0.23 f 0.08* 53.4 f 16.0* 0.01 f 0.01 9.7 + 8.0* 0.55 + 0.23 26.8 f 12* 
PCT 0.11 * 0.027 67.2 k 7.0?” 0.01 f 0.0 3.17 f 2.5 0.03 f 0.02t 3.6 +- 3.7t 
Note. Tissue distribution data (2 f SE) were determined at 15 min after intravenous injection and expressed as 
percentage injected dose phagocytized per gram (%ID/g) and per total organ (%ID/TO). 
* P < 0.01, PCS versus control. 
t P < 0.05, PCS versus PCT. 
m P < 0.05, PCT versus control. 
volve all three zones of the hepatic lobule. In 
contrast, only the central and terminal hepatic 
venule zones became dilated in the PCT group. 
In both PCS and PCT groups hepatic nuclei 
appeared variable in size. Kupffer cells in PCS 
livers were more abundant and contained 
more refractile amphophilic material as com- 
pared to PCT or controls. 
Transmission electron microscopy dem- 
onstrated a significant reduction in hepatocyte 
glycogen following PCS. An intermediate loss 
of intracellular glycogen was noted in the PCT 
group. Mitochondria were more abundant in 
both groups compared to controls, but were 
more variable in size following PCS. Rough 
endoplasmic reticulum appeared less promi- 
nent and somewhat fragmented following both 
PCS and PCT, but these changes were most 
prominent after PCS. The Spaces of Disse were 
dilated in both groups, but increased collagen 
content in these spaces was found only after 
PCS. Following PCS, the Kupffer cells were 
markedly enlarged and contained abundant 
phagolysosomes filled with osmophilic debris. 
In contrast, after PCT, Kupffer cells were of 
more normal size and contained fewer phago- 
lysosomes. 
DISCUSSION 
Early investigations of liver physiology 
stressed the importance of portal blood and 
hypothesized that hepatotrophic factors were 
critical for normal hepatocellular regeneration 
[20]. Child and others later suggested that he- 
patic maintenance was determined not by 
trophic factors contained in portal blood but 
rather by total portal blood flow per se [8]. 
Although useful only as rough estimates of 
hepatic synthetic activity, serum levels of al- 
bumin and total protein remained near nor- 
mal following PCT in the present study. In- 
creased levels of SGOT and SGPT observed 
in the early postoperative period in PCS and 
PCT groups presumably represented a non- 
specific injury response to alterations in portal 
blood flow. The rapid return to normal of 
these values after operation and continued 
normal levels, especially after PCT, suggested 
restoration and maintenance of hepatocellular 
integrity. Serum total protein and albumin 
fell progressively in the PCS group, pointing 
to a defect in the liver’s ability to synthesize 
these serum proteins. Transaminase levels in 
the PCS group were significantly elevated 
above control and PCT values in nearly all 
study periods. Presumably complete portal 
blood flow diversion had a long-lasting effect 
on hepatocyte integrity and function. 
The liver weight-to-body weight ratio de- 
creased significantly in the PCS group; this 
was not observed following PCT. After PCS 
there was significant microscopic evidence of 
hepatic atrophy with deglycogenation, loss of 
rough endoplasmic reticulum, and incomplete 
restoration of hepatocellular mass. Although 1 O-fold increase in splenic tracer activity after 
there was some loss of hepatocyte glycogen PCS may simply be a manifestation of the 
after PCT, the extent of loss was much less “spillover phenomenon” described by Brad- 
than after PCS and liver mass was better field [5] and Carr [6]. One would not expect 
maintained. Maximum hepatocyte loss in this finding after PCT because hepatic blood 
PCT animals occurred mainly in the pericen- flow and therefore colloid delivery remain 
tral hepatic venous zone. Experimentally, normal. HRES extraction efficiency is deter- 
acute diversion of portal blood flow in dogs mined largely by organ blood flow or the rate 
results in hepatocyte loss and progressive he- of delivery of particles to the macrophage sys- 
patocellular dysfunction [4, 11,20,29]. These tem [3, 23, 241. In fact, there is an inverse 
changes may be manifest long-term as organ relationship between extraction efficiency and 
atrophy and ultimately as hepatic failure re- blood flow. The shift of Tsc activity to extra- 
sulting from organelle dysfunction. Our data hepatic sites after PCT may also have been 
would suggest that maintenance of total he- due to increased sinusoidal blood flow and 
patic blood flow despite portal diversion can therefore decreased extraction efficiency. 
decrease the severity of morphological changes Recent work by Blumenstock and others 
induced at both macro and microscopic levels. [2,3] has partially characterized serum opsonic 
Although estimated hepatic blood flow factors which mediate RES clearance of blood- 
(EHBF) fell after PCS and increased sharply borne particulate matter. These substances 
following PCT, estimated blood flow per gram appear to be glycoproteins, one of which may 
of liver increased following both procedures. be identical to cold-insoluble globulin (CI,) 
In fact, EHBF on a milliliter/minute/gram [25, 261 or fibronectin. CI, is distributed in 
liver basis was similar between PCS and PCT many tissues in bound and soluble forms and 
groups. Following PCS the ratio of liver weight constitutes an important structural compo- 
to body weight decreased by 38% compared nent of basement membranes [28]. High con- 
to control and PCT ratios. These data suggest centrations of this protein are also found along 
that maintenance of EHBF in the PCS group the sinusoids of the liver [28] and in tissue 
resulted from a reduction in perfused liver cultures of endothelial cells and can be dem- 
mass rather than from a compensatory in- onstrated using immunofluorescent staining 
crease in overall flow. techniques on vascular endothelial surfaces 
The total amount of radioactive tracer [ 16, 181. Although circulating CI, and cell sur- 
phagocytized by the liver decreased by 23 and face fibronectin appear to be antigenically 
54% after PCT and PCS, respectively. There similar, they may have distinctly different bi- 
was no consistent increase in uptake in ex- ologic roles [26]. 
trahepatic sites of reticuloendothelial activity In the present study serum opsonic activity 
such as spleen, lung, and bone marrow fol- decreased by 65% 6 weeks after PCS. In con- 
lowing PCT. In contrast, tracer activity in trast, opsonic activity decreased transiently in 
spleen and lung increased by 400 and 420%, the PCT group but stabilized at 77% of control 
respectively, after PCS (Table 1) and after PCS values. These changes were accompanied by 
the percentage of injected Tsc per gram tissue no measurable changes in the serum a2-pro- 
increased in the liver by 39% despite a decrease tein levels as determined by serum protein 
in the ratio of liver weight to body weight. electrophoresis in either PCS or PCT group 
Acute portal diversion appeared to have a up to 9 weeks after operation. The decreased 
negligible effect on the hepatic RES system; levels of opsonic activity observed after PCS 
in contrast, the marked decrease in liver may have resulted from several factors. Pro- 
weight/body weight and reduced serum pro- gressive hepatocellular dysfunction may have 
tein levels observed after PCS were consistent led to decreased synthesis of cwz-glycoprotein 
with a defect at the hepatocyte level. Similar to a level insufficient for normal opsono- 
findings were not observed following PCT. The phagocytosis. Alternatively, peripheral con- 
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sumption of opsonic proteins may have been 
increased because of iatrogenically induced 
portal-systemic shunting. Elevated peripheral 
levels of endotoxin or other potentially anti- 
genie material which ordinarily would have 
been removed by the liver may have induced 
or contributed to this phenomenon. 
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